16
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Short-term Risk for AIDS-indicator Diseases Predicted by Plasma HIV-1 RNA and CD4+ Lymphocytes

Pages 37-42 | Published online: 08 Jul 2009

  • Crowe SM, Carlin JB, Stewart KI, Lucas CR, Hoy JF. Predicitive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immun Defic Syndr 1991; 4: 770–6.
  • Masur H, Ognibene F, Yarchoan R, Shelhamer JH, Baird BF, Travis W, et al. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus infection. Ann Intern Med 1989; 111: 223–31.
  • Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272: 1167–70.
  • O’Brien WA, Hartigan PM, Martin D, Esinhart J, Hill A, Benoit S, et al. Changes in plasma HIV-1 RNA and CD4 + lymphocyte counts and the risk of progression to AIDS. N Engl J Med 1996; 334: 426–31.
  • Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, et al. Plasma viral load and CD4 + lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126: 946–54.
  • Saag MS. Use of HIV viral load in clinical practice: back to the future. Ann Intern Med 1997; 126: 983–5.
  • Katzenstein TL, Pedersen C, Nilesen C, Lundgren JD, Jakobseb PH, Gerstoft J. Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome. AIDS 1996; 10: 167–73.
  • Ruiz L, Romeu J, Clotet B, Balague M, Cabrera C, Sirera G, et al. Quantitative HIV-1 RNA as a marker of clinical stability and survival in a cohort of 302 patients with a mean CD4 cell count of 300 × 106/l. AIDS 1996; 10: F39–44.
  • O’Brien WA, Hartigan PM, Daar ES, Simberkoff MS, Hamilton JD. Changes in plasma HIV RNA levels and CD4 + lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. Ann Intern Med 1997; 126: 939–45.
  • Hughes MD, Johnson VA, Hirsch MS, Bremer JW, Elbeik T, Erice A, et al. Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. Ann Intern Med 1997; 126: 929–38.
  • Bush Ch E, Donovan RM, Markowitz NP, Kvale P, Saravolatz L. A study of HIV RNA viral load in AIDS patients with bacterial pneumonia. J Acquir Immune Defic Syndr 1996; 13: 23–6.
  • Centers for Disease Control. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescent and adults. MMWR 1992; 41: 1–19.
  • Mulder J, McKinney N, Christopherson C, Sninsky J, Greefield L, Kwok S. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA plasma: application to acute retroviral infection. J Clin Microbiol 1994; 32: 292–303.
  • Fisher Ll, Van Belle G. Biostatistics. A Methodology for the Health Sciences. New York: John Wiley & Sons Inc., 1993.
  • Collet D. Modelling Survival Data in Medical Research. London: Chapman & Hall, 1994.
  • Vining DJ, Gladish G. Receiver operating characteristic curves: a basic understanding. RadioGraphics 1992; 12: 1147–54.
  • Hanley JA, McNeil BJ. A method for comparing the area under the two ROC curves derived from the same cases. Radiology 1983; 148: 839–43.
  • Race EM, Adelson-Mitty J, Kriegel GR, et al. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease. Lancet 1998; 351: 252–5.
  • Moore RD, Chaisson RE. Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med 1996; 124: 633–42.
  • Palella FJ, Delaney KM, Moorman A, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853–60.
  • Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet 1998; 352: 1725–30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.